je.st
news
Mannkind investors raise stock manipulation allegations
2015-05-22 05:24:51| Biotech - Topix.net
Hakan Edstrom, President, CEO and Director of MannKind Corporation, speaks at its annual stockholders meeting on Thursday, May 21, 2015. MannKind Corp. recently gained approval from the FDA for a new form of insulin.
Tags: stock
raise
investors
manipulation
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||